Trulieve Cannabis Corp. (TRLV)
| Market Cap | 1.80B |
| Revenue (ttm) | 1.08B -9.1% |
| Net Income | -445.60M |
| EPS | -2.32 |
| Shares Out | 192.81M |
| PE Ratio | n/a |
| Forward PE | 31.69 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,655,367 |
| Open | 10.00 |
| Previous Close | 10.02 |
| Day's Range | 9.23 - 10.25 |
| 52-Week Range | 4.62 - 13.28 |
| Beta | 1.92 |
| Analysts | Strong Buy |
| Price Target | 18.32 (+95.94%) |
| Earnings Date | Nov 5, 2026 |
About TRLV
Trulieve Cannabis Corp. operates as a cannabis retailer in the United States. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery. It sells flowers, edibles, vapes, oral, topical, concentrates, and accessories under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, and Roll One brands. The company operates dispensaries in Florida, Arizona, Georgia, Ohio, Maryland, West Virginia, Connecticut, and Pennsyl... [Read more]
Financial Performance
In 2025, Trulieve Cannabis's revenue was $1.18 billion, a decrease of -0.45% compared to the previous year's $1.19 billion. Losses were -$116.38 million, -24.97% less than in 2024.
Financial StatementsAnalyst Summary
According to 7 analysts, the average rating for TRLV stock is "Strong Buy." The 12-month stock price target is $18.32, which is an increase of 95.94% from the latest price.
News
Trulieve Cannabis to open medical cannabis dispensary in Tampa, Florida
Trulieve Cannabis (TRLV) announced the opening of a new medical cannabis dispensary in Tampa, Florida. The dispensary will host a grand opening on Friday, November 20.
Trulieve to Open Medical Cannabis Dispensary in Tampa, Florida
New Hillsborough County location will host grand opening celebration Friday, November 20 TALLAHASSEE, Fla., Nov. 16, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Compa...
Trulieve Cannabis set to join to Russell 2000 and 3000 indices
Trulieve Cannabis (TRLV) announced that the company is set to join to the Russell 2000 and 3000 Indices as part of the semi-annual Russell Indexes reconstitution, according to a preliminary…
Trulieve Announces Preliminary Addition to the Russell 2000® and 3000® Indices
TALLAHASSEE, Fla., Nov. 16, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced ...
Trulieve Announces November 2026 Event Participation
TALLAHASSEE, Fla., Nov. 11, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced ...
Trulieve Expands Medical Cannabis Access through Riverside Pharmacy in Gainesville, Georgia
New Trulieve-branded kiosk offers qualified patients product access, education, and personalized guidance TALLAHASSEE, Fla., Nov. 10, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Truli...
Marijuana Stocks In 2027: New Risks And Opportunities For Investors
Marijuana stocks continue to attract investors, but trading in the cannabis sector requires understanding risks that extend far beyond quarterly revenue. Regulatory decisions, limited access to exchan...
Trulieve Cannabis reports Q3 adjusted EPS 9c, consensus 7c
Reports Q3 revenue $230M, consensus $221.63M. “State licensed medical marijuana rescheduling unlocked major milestones including DEA registration, removal of 280E tax, and uplisting to the NYSE,” said...
Trulieve Reports Third Quarter 2026 Results
Third quarter revenue of $230 million, with 64% gross margin Cash flow from operations of $183 million and free cash flow of $120 million* in first nine months of 2026 Received final DEA registrations...
Trulieve Cannabis receives registrations for medical marijuana dispensaries
Trulieve Cannabis (TRLV) announced that Trulieve has received registrations for medical marijuana dispensaries as part of the initial registrations issued by the U.S. Drug Enforcement Administration. ...
Trulieve Receives DEA Registrations for State-Licensed Medical Marijuana Operations
TALLAHASSEE, Fla., Nov. 2, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced t...
Marijuana Stocks And The Changing U.S. Cannabis Industry
Marijuana stocks are entering a market where financial discipline may matter more than rapid expansion. The cannabis industry continues to generate substantial consumer activity. However, today's inve...
Cannabis Stocks in 2027: New Markets, Reform And Investment Risks
Marijuana stocks to watch in 2027 may be shaped by a combination of state launches, federal rulemaking, and changing competition between licensed cannabis and intoxicating hemp products. That calendar...
Marijuana Stocks Expand Beyond Traditional Cannabis Companies
Marijuana stocks could soon see a big jump in overall momentum in the near future. Most of this is based on the growth and expansion of certain public companies. In 2026, we are soon to see the offici...
Trulieve Cannabis repays $65M mortgage, reduces debt to $225M
Trulieve Cannabis (TRLV) announced the full repayment of an approximately $65M mortgage notes payable secured by a cultivation site in Jefferson County, Florida, thereby reducing outstanding debt to a...
Trulieve Repays $65 Million Mortgage Strengthening Balance Sheet
TALLAHASSEE, Fla., Oct. 7, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced t...
Trulieve Cannabis Corp. to Hold Third Quarter 2026 Results Conference Call on November 5, 2026
TALLAHASSEE, Fla., Oct. 6, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., will hold a conf...
Cannabis Stocks Are Slumping. A Procedural DEA Delay Is to Blame.
Trulieve Cannabis falls after the Drug Enforcement Administration pauses pending rescheduling proceedings for a case that could federally recognize cannabis for medical use.
Trulieve Cannabis falls -16.0%
Trulieve Cannabis (TRLV) is down -16.0%, or -$1.98 to $10.43.
Trulieve Cannabis falls -13.1%
Trulieve Cannabis (TRLV) is down -13.1%, or -$1.62 to $10.79.
3 Cannabis Stocks to Watch Heading Out of September
The marijuana industry is entering another important period for investors as September 2026 gets underway. Cannabis stocks have experienced significant volatility over the past several years. However,...
Trulieve Cannabis announces licensing deal with Connected
Trulieve Cannabis (TRLV) announced a licensing deal with Connected for the exclusive rights to genetics, trademarks, and proprietary know-how to produce and sell Alien Labs and Connected branded canna...
Trulieve Announces Exclusive Master Licensing Agreement with Connected for Florida and Texas
Perpetual Royalty-Free License Covers Alien Labs and Connected Brands TALLAHASSEE, Fla., Sept. 28, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading an...
Cannabis Stocks Enter A New Era For Investors nd Enthusiasts
Cannabis stocks are entering a potentially transformative period as federal reform takes hold. Stronger business fundamentals and wider market access are reshaping the legal cannabis industry. For can...
Trulieve Cannabis Corp. Added to S&P Total Market and S&P Completion Indices
Inclusion Marks Another Milestone as Trulieve Broadens U.S. Capital Markets Exposure TALLAHASSEE, Fla., Sept. 22, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"...